Concepedia

Hongxia Zheng

HZ

Statistics

Publications

9

Citations

748

H-Index

9

Active since

2002

Affiliations

St. Jude Children's Research Hospital(Current)

University of Pittsburgh

University of Southern California

Merck KGaA, Darmstadt (Germany)

University of California San Diego

Hongxia Zheng is an author at St. Jude Children's Research Hospital specializing in pharmacology, pharmacogenomics, and pharmacogenetics.

Publications per year

2002–2025

9

Publications

9

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

Hongxia Zheng, Steven Webber, Adriana Zeevi et al. · American Journal of Transplantation · 2003 · 266 citations · Full text

, , +17

Tacrolimus Dosing in Adult Lung Transplant Patients Is Related to Cytochrome P4503A5 Gene Polymorphism

Hongxia Zheng, Adriana Zeevi, Erin G. Schuetz et al. · The Journal of Clinical Pharmacology · 2004 · 150 citations

, , +16

The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients

Hongxia Zheng, Steven Webber, Adriana Zeevi et al. · Human Immunology · 2002 · 109 citations

, , +15

Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China

Zhitao Ying, Haiyan Yang, Ye Guo et al. · Cancer Medicine · 2020 · 100 citations · Full text

, , +17

Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 nonexpressors

Jian Wang, Adriana Zeevi, Kenneth R. McCurry et al. · Transplant Immunology · 2005 · 63 citations

, , +13

1–5 of 9